SLGL vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 01, 2026

SLGL

46.7
AI Score
VS
SLGL Wins

CBIO

40.6
AI Score

Investment Advisor Scores

SLGL

47score
Recommendation
HOLD

CBIO

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric SLGL CBIO Winner
Forward P/E 9.3371 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -96.6% 0.0% CBIO
Earnings Growth 487.6% 0.0% SLGL
Tradestie Score 46.7/100 40.6/100 SLGL
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

SLGL 1M: -19.1% · 3M: -33.6% CBIO 1M: +14.2% · 3M: -16.2%

Current Technical Phase

SLGL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.2%), weak momentum, RSI 32

RSI (14): 32.0 · Price: $56.25

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.3 · Price: $14.37

Fundamentals Snapshot

Metric SLGL CBIO
Market Cap — —
Forward P/E -7.0 -5.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -1.0% 0.0%
Gross Margin -7.8% 1.0%
Operating Margin -9.9% -14.3%
EPS -5.61 -7.20
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SLGL is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.